Molecular Formulations logo — Delivering Precision in Pharmaceutical Sciences Through Inno...

Molecular Formulations

Delivering Precision in Pharmaceutical Sciences Through Innovative Drug Development

Founded 2004 Seed Biotechnology, Pharmaceutical

General Information

Company Name Molecular Formulations
Founded Year 2004
Industries Biotechnology, Pharmaceutical
Funding Stage Seed
Social

Get notified when Molecular Formulations moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Molecular Formulations

Molecular Formulations is a life sciences research and development company that offers an extensive range of services in pharmaceutical sciences to clients in the pharmaceutical and biotechnology sectors. Specializing in high-value R&D services, the company focuses on physicochemical characterization, prototype formulation, and stability study evaluation. Their drug development services and technologies are designed to determine the drug-like properties of molecules and develop prototype formulations suitable for toxicology and dose-ranging studies. Molecular Formulations, LLC is the latest addition to the Flavin Ventures, LLC portfolio. Flavin Ventures, LLC is an early-stage venture capital and management group that provides support to innovative Midwestern life sciences companies focused on drug discovery. Molecular Formulations was founded in 2004, and its last investment was a Seed Round investment by Flavin Ventures on 24 March 2004. Overall, Molecular Formulations aims to deliver precision in pharmaceutical sciences through innovative drug development, and its partnership with Flavin Ventures signals potential and commitment to staying at the forefront of the industry.

Taxonomy: pharmaceutical sciences, drug development, R&D services, physicochemical characterization, prototype formulation, stability study evaluation, biotechnology sectors, toxicology studies, dose-ranging studies, Flavin Ventures, venture capital, Midwestern life sciences, drug discovery, early-stage, biotechnology companies

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1 •••• •••• 24 Mar 2004

Molecular Formulations Alternatives & Competitors

Molecular Formulations vs

Caliper, A PerkinElmer Company, is a research tools company engaged in the sale of innovative and en...

Seed
148 employees
Biotechnology, Pharmaceutical
Molecular Formulations vs
Nabla Bio
Nabla Bio United States

Designing antibodies with atomic precision

25 employees
Molecular Formulations vs

Fundraising for Life Sciences companies in high-risk therapeutic areas. Experience $5M-$60M

2 employees
Biotechnology, Health Care

FAQ About Molecular Formulations

Delivering Precision in Pharmaceutical Sciences Through Innovative Drug Development
Molecular Formulations was founded in 2004.
Molecular Formulations operates in the following industries: Biotechnology, Pharmaceutical.
Molecular Formulations has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Molecular Formulations include Caliper Life Sciences, Nabla Bio, Kerentech, Chemical Computing Group, Nine Square Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Molecular Formulations and Caliper Life Sciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Molecular Formulations and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy